Tweet
December 23, 2020
by OnCuba Staff in Cuba
After having approved phase 2 of clinical trials of its second vaccine candidateto prevent COVID-19, called Soberana 02, Cuba began vaccinating volunteers, Havana’s Finlay Institute reported this Tuesday.
... In this Cuban vaccine candidate, the virus antigen and tetanus toxoid are combined, as the director general of the Finlay Vaccine Institute, Vicente V?rez, recently explained.
by OnCuba Staff in Cuba
After having approved phase 2 of clinical trials of its second vaccine candidateto prevent COVID-19, called Soberana 02, Cuba began vaccinating volunteers, Havana’s Finlay Institute reported this Tuesday.
... In this Cuban vaccine candidate, the virus antigen and tetanus toxoid are combined, as the director general of the Finlay Vaccine Institute, Vicente V?rez, recently explained.